Nuclear Vav3 is required for polycomb repression complex-1 activity in B-cell lymphoblastic leukemogenesis.

Area of Science:

• Oncology
• Molecular Biology
• Cell Signaling

Background:

• Acute B-cell lymphoblastic leukemia (B-ALL) arises from the evolution of B-cell progenitors.
• The oncogenic BCR-ABL fusion protein drives B-ALL leukemogenesis.
• Rac guanine nucleotide exchange factor (Rac GEF) Vav3 and Rac GTPases are implicated in this process.

Purpose of the Study:

• To investigate the role of Vav3 in BCR-ABL-mediated leukemogenesis.
• To elucidate the molecular mechanisms by which Vav3 regulates B-ALL cell proliferation and self-renewal.
• To understand the interaction of Vav3 with the Polycomb Repression Complex (PRC) in the nucleus.

Main Methods:

• Analysis of Vav3 localization and interaction with BCR-ABL, Rac, and PRC proteins (Bmi1, Ring1b, Ezh2) in the nucleus.
• Assessment of Vav3's GEF activity's role in proliferation, self-renewal, and H2AK119Ub.
• Investigation of Vav3's effect on negative regulators of cell proliferation and oncogenic transcriptional factors.
• Examination of Vav3's role in preventing Bmi1 phosphorylation by Phlpp2 and Akt.

Main Results:

• Vav3 localizes to the nucleus upon BCR-ABL expression and interacts with PRC components.
• Vav3's GEF activity is essential for leukemic B-cell progenitor proliferation, self-renewal, nuclear Rac activation, and H2AK119Ub.
• Vav3 deficiency leads to de-repression of proliferation inhibitors and repression of oncogenic factors.
• Vav3 prevents Bmi1 phosphorylation at S314, which is critical for transcriptional reprogramming of leukemic cells.

Conclusions:

• Non-canonical nuclear Rho GTPase signaling, particularly involving Vav3, is vital for B-ALL pathogenesis.
• Vav3 acts as a key regulator of B-ALL cell identity and proliferation through its interaction with Bmi1 and the PRC.
• Targeting Vav3 signaling may offer a novel therapeutic strategy for B-ALL.